BDBM393105 5-(3-chloro-4- fluorobenzenesulfon- amidomethyl)-N-[(1- methyl-1H-pyrrol-2- yl)methyl]pyrazine-2- carboxamide::US9963434, Table 12.50

SMILES Cn1cccc1CNC(=O)c1cnc(CNS(=O)(=O)c2ccc(F)c(Cl)c2)cn1

InChI Key InChIKey=NXWVCBZSOIPSJI-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 393105   

TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Luc Therapeutics

US Patent
LigandPNGBDBM393105(US9963434, Table 12.50 | 5-(3-chloro-4- fluorobenz...)
Affinity DataIC50: 3.09E+3nMAssay Description:Cell Culture and plating: HEK293 cells expressing NR1/NR2A (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2020
Entry Details
Go to US Patent